BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 2475265)

  • 1. CBVPM/AVBP versus HCOMLA chemotherapy in non-Hodgkin lymphoma patients.
    Pawelski S; Konopka L; Pakulska J; Gutkowska J
    Chemioterapia; 1987 Jun; 6(2 Suppl):716-9. PubMed ID: 2475265
    [No Abstract]   [Full Text] [Related]  

  • 2. Results of three polychemotherapy programs in non-Hodgkin's lymphomas.
    Konopka L; Pawelski S
    J Chemother; 1989 Jul; 1(4 Suppl):1259-62. PubMed ID: 16312857
    [No Abstract]   [Full Text] [Related]  

  • 3. [Results of treating patients with highly malignant non-Hodgkin's lymphomas; comparison of treatment efficacy with CHOP and CBVPM-AVBP].
    Urasiński I; Zdziarska B; Wichert K; Zuk E
    Pol Merkur Lekarski; 1998 Mar; 4(21):137-9. PubMed ID: 9640064
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Stevens-Johnson syndrome associated with methotrexate treatment for non-Hodgkin's lymphoma.
    Cuthbert RJ; Craig JI; Ludlam CA
    Ulster Med J; 1993 Apr; 62(1):95-7. PubMed ID: 7685956
    [No Abstract]   [Full Text] [Related]  

  • 5. [Treatment of medium and highly malignant non-Hodgkin's lymphoma with combined chemotherapy using methotrexate, adriamycin, cyclophosphamide, vincristine, prednisone and bleomycin (protocol MACOP-B)].
    Pittrová H; Koza V; Vozobulová V; Cetkovský P; Skopek P; Jungerová J; Cepelák V
    Vnitr Lek; 1989 Dec; 35(12):1177-82. PubMed ID: 2483776
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Vibrio cholerae can be encountered even at home].
    Sinisalo M; Oksanen K; Koivisto V; Vikberg V
    Duodecim; 1991; 107(22):1880-3. PubMed ID: 1285425
    [No Abstract]   [Full Text] [Related]  

  • 7. Impairment of peripheral nervous system in patients with non-Hodgkin's lymphomas treated with CBVPM/AVBP and CHOP schedules.
    Nowacki P; Dolińska D; Stankiewicz J; Grzelec H
    Acta Haematol Pol; 1992; 23(2):111-6. PubMed ID: 1283282
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A clinical phase II study of ProMACE-CytaBOM.
    Dahlberg S; Miller TP; Fisher RI
    J Clin Oncol; 1991 May; 9(5):888. PubMed ID: 1707958
    [No Abstract]   [Full Text] [Related]  

  • 9. Non-hodgkins lymphoma.
    Mead G; Woodcock J; Young C
    Clin Evid; 2003 Jun; (9):1-21. PubMed ID: 12967352
    [No Abstract]   [Full Text] [Related]  

  • 10. CHOP versus intensive regimens in non-Hodgkin's lymphoma.
    Longo DL; DeVita VT; Young RC
    N Engl J Med; 1993 Aug; 329(8):580-1; author reply 581-2. PubMed ID: 7687747
    [No Abstract]   [Full Text] [Related]  

  • 11. [Low-grade non-Hodgkin's lymphoma: intensive combined chemotherapy].
    Hattori M; Motomura S; Tomita N; Taguchi J; Tanabe J; Sakai R; Fujisawa S; Fukawa H; Kanamori H; Mouri H; Maruta A; Kodama F; Okubo T
    Rinsho Ketsueki; 1996 Feb; 37(2):101-8. PubMed ID: 8852026
    [TBL] [Abstract][Full Text] [Related]  

  • 12. What constitutes "improved prognosis"?
    Canellos GP
    J Clin Oncol; 2008 Apr; 26(12):1913-4. PubMed ID: 18421041
    [No Abstract]   [Full Text] [Related]  

  • 13. Comparison of front-line chemotherapy for aggressive non-Hodgkin's lymphoma using the CAP-BOP regimens. The Nebraska Lymphoma Study Group.
    Vose JM; Anderson JR; Bierman PJ; Bast M; Weisenburger D; Chan WC; Bishop MR; Armitage JO
    Semin Hematol; 1994 Apr; 31(2 Suppl 3):4-8. PubMed ID: 7521065
    [No Abstract]   [Full Text] [Related]  

  • 14. Effects of Mega-COMLA (cyclophosphamide, cytarabine, vincristine, and methotrexate followed by leucovorin and prednisone) plus CHOP (cyclophosphamide, doxorubicin, vincristine, and prednisone) in the treatment of lymphoid neoplasms with very poor prognosis.
    Hainsworth JD; Wolff SN; Stein RS; Greer JP; Cousar JB; Greco FA
    Cancer Treat Rep; 1986 Aug; 70(8):953-8. PubMed ID: 3015406
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Minimizing toxicity of MACOP-B.
    Connors JM; Klimo P
    J Clin Oncol; 1987 Aug; 5(8):1302-3. PubMed ID: 2442319
    [No Abstract]   [Full Text] [Related]  

  • 16. [Treatment of malignant lymphoma with extranodal lesions--current trends and new strategies in chemotherapy].
    Okumura H
    Rinsho Ketsueki; 1999 Mar; 40(3):196-8. PubMed ID: 10222625
    [No Abstract]   [Full Text] [Related]  

  • 17. [Thyroid lymphoma in a 51-year-old woman].
    Herranz MT; Corrales A; Molina MA; Redondo E; Almagro M; Martí J
    An Med Interna; 1993 Mar; 10(3):132-4. PubMed ID: 7683502
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Treatment of localized lymphoma.
    Tanvetyanon T
    N Engl J Med; 2005 Jun; 352(23):2449-51; author reply 2449-51. PubMed ID: 15944432
    [No Abstract]   [Full Text] [Related]  

  • 19. [Nutritional and defunctionalized jejunostomy in the chemotherapeutic treatment of gastric non-Hodgkin's lymphoma. Preliminary experience].
    Messinetti S; Martelli M; Giacomelli L; Brescia A; Miglietta AM; Pulcini A; Finizio R; Porcelli C
    Ann Ital Chir; 1993; 64(3):295-300. PubMed ID: 7509128
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Long-term follow-up of non-Hodgkin's lymphoma patients treated with ProMACE-CytaBOM: an effective regimen for the intermediate grade subtype.
    Marotta G; Bigazzi C; Bocchia M; Forconi F; Lauria F
    Haematologica; 1998 Sep; 83(9):853-4. PubMed ID: 9825583
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.